Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MYNZ is expected to report earnings to fall 68.87% to -240 cents per share on September 03
Q2'25
Est.
$-2.40
Q4'24
Missed
by $1.31
Q3'24
Missed
by $4.27
Q2'24
Missed
by $19.45
Q1'24
Missed
by $0.06
The last earnings report on April 01 showed earnings per share of -771 cents, missing the estimate of -640 cents. With 45.94K shares outstanding, the current market capitalization sits at 6.55M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MYNZ showed earnings on April 01, 2025. You can read more about the earnings report here.